|
Market Closed -
Nasdaq
16:30:00 2026-08-31 EDT
|
5-day change | 1st Jan Change | ||
| 2.490 USD | +0.81% |
|
-5.15% | +7.33% |
| 06-30 | XTL Biopharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 06-29 | XTL Biopharmaceuticals Ltd. acquired Psyga Bio Ltd. | CI |
Chart: Technical Analysis
Stock exchange
Nasdaq
XTLB 2.490 $
+0.81%
18.99K
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| XTLB | 2.490USD | +0.81% | 18.99K $ | |
CBOE
| XTLB | 2.480USD | -3.50% | 248 $ | |
|
Deutsche Boerse AG
| HHB0 | 1.950EUR | +10.17% | 0 € | |
|
Börse Stuttgart
| HHB0 | 1.950EUR | +10.17% | 0 € | |
|
Boerse Muenchen
| HHB0 | 2.160EUR | 0.00% | 0 € | |
TEL AVIV STOCK EXCHANGE
| XTLB | 1.900ILa | 0.00% | 200K ILa |
- Stock Market
- Stocks
- XTLB Stock
- XTLB Stock
- Charts XTL Biopharmaceuticals Ltd.
Select your edition
All financial news and data tailored to specific country editions
